Advanced search
1 file | 980.82 KB

In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent model

(2012) NUCLEAR MEDICINE AND BIOLOGY. 39(6). p.854-863
Author
Organization
Keywords
Pharmacokinetics, PET, beta-glucuronidase, Prodrug, Necrosis and inflammation, TUMOR-SELECTIVE CHEMOTHERAPY, HUMAN OVARIAN-CANCER, DIFFERENTIATING TUMOR, PRODRUG DOX-GA3, GENE-THERAPY, INFLAMMATION

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 980.82 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Antunes, Inês F, Hidde J Haisma, Philip H Elsinga, Jurgen WA Sijbesma, Aren van Waarde, Antoon TM Willemsen, Rudi Dierckx, and Erik FJ de Vries. 2012. “In Vivo Evaluation of [18F]FEAnGA-Me: a PET Tracer for Imaging Β-glucuronidase (β-GUS) Activity in a Tumor/inflammation Rodent Model.” Nuclear Medicine and Biology 39 (6): 854–863.
APA
Antunes, Inês F, Haisma, H. J., Elsinga, P. H., Sijbesma, J. W., van Waarde, A., Willemsen, A. T., Dierckx, R., et al. (2012). In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent model. NUCLEAR MEDICINE AND BIOLOGY, 39(6), 854–863.
Vancouver
1.
Antunes IF, Haisma HJ, Elsinga PH, Sijbesma JW, van Waarde A, Willemsen AT, et al. In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent model. NUCLEAR MEDICINE AND BIOLOGY. 2012;39(6):854–63.
MLA
Antunes, Inês F, Hidde J Haisma, Philip H Elsinga, et al. “In Vivo Evaluation of [18F]FEAnGA-Me: a PET Tracer for Imaging Β-glucuronidase (β-GUS) Activity in a Tumor/inflammation Rodent Model.” NUCLEAR MEDICINE AND BIOLOGY 39.6 (2012): 854–863. Print.
@article{3151148,
  author       = {Antunes, In{\^e}s F and Haisma, Hidde J and Elsinga, Philip H and Sijbesma, Jurgen WA and van Waarde, Aren and Willemsen, Antoon TM and Dierckx, Rudi and de Vries, Erik FJ},
  issn         = {0969-8051},
  journal      = {NUCLEAR MEDICINE AND BIOLOGY},
  keyword      = {Pharmacokinetics,PET,beta-glucuronidase,Prodrug,Necrosis and inflammation,TUMOR-SELECTIVE CHEMOTHERAPY,HUMAN OVARIAN-CANCER,DIFFERENTIATING TUMOR,PRODRUG DOX-GA3,GENE-THERAPY,INFLAMMATION},
  language     = {eng},
  number       = {6},
  pages        = {854--863},
  title        = {In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging \ensuremath{\beta}-glucuronidase (\ensuremath{\beta}-GUS) activity in a tumor/inflammation rodent model},
  url          = {http://dx.doi.org/10.1016/j.nucmedbio.2012.02.002},
  volume       = {39},
  year         = {2012},
}

Altmetric
View in Altmetric
Web of Science
Times cited: